ENTITY
Alphamab Co Ltd

Alphamab Co Ltd (9966 HK)

144
Analysis
Health Care • China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
•07 Feb 2021 09:31

China Healthcare Weekly (Feb.5)

This article analyzed the results of the 4th volume-based purchase, the CTLA-4 antibody drug industry, the orthopedic implant device market, news...

Logo
454 Views
Share
•25 Jan 2021 09:52

China Healthcare Weekly (Jan.22)

The article analyzed the new official document for the volume-based purchase,industry viewpoints on China cryogenic storage market and “AI +...

Logo
408 Views
Share
•28 Dec 2020 09:42

China Healthcare Weekly (Dec.25)

This article analyzed healthcare industry viewpoints such as competitive landscape of PD-1/L1 in China, news of Alphamab, Hengrui, Innovent and...

Logo
530 Views
Share
•30 Jul 2019 22:34

Greater Bay Area Initiative - Viablity & Investor Implications, Part II

Last week in Part I we discussed what the GBA Initiative is. The importance of the GBA Initiative cannot be overstated. It is critical to the...

Share
bearish•Cross Asset Strategy
•28 Jul 2019 13:24

🇨🇳🇭🇰 That Was The Week That Was • China/Hong Kong 22nd-27th July 2019 @Smartkarma

TW3 CHINA/HONG KONG 22-27 JUNEThis TW3 covers China and Hong Kong and is a companion to the North Asian TW3 published earlier today.  The weight of...

Logo
781 Views
Share
x